share_log

弘和仁爱医疗(3869.HK):中国具备丰富经验的医院运营管理集团

Honghe Benevolence Medical (3869.HK): a hospital operation and management group with rich experience in China

光大證券 ·  Mar 1, 2017 00:00  · Researches

The company is a hospital operation and management group led by a professional team with rich experience in hospital management. Through the operation and management of hospitals, the company plans to integrate the medical resources in the region where its hospitals are located and build a regional medical service center to provide continuous, systematic, convenient and high-quality comprehensive medical services for residents in these areas. As the core platform of hospital operation and management business invested by Hony, the company focuses on the diagnosis and treatment of common diseases, frequently occurring diseases and chronic diseases. The company has a dedicated management team with rich experience and strong executive ability (especially comprehensive experience in hospital management). The core management team mainly includes members with working experience in tertiary hospitals and major medical staff in hospitals managed by the company with rich experience in hospital management. The company implements a standardized and process management system, and improves the overall management, reception capacity and operation efficiency of the hospital according to the background and situation of each hospital.

The company has rich investment experience. The company can expand through mergers and acquisitions, targeting secondary and tertiary hospitals or hospitals with the same size, excellent performance in medical specialties, and located in areas with large population and attractive economic conditions.

With these hospitals as the starting point, the company strives to integrate the medical resources in the region and set up a regional medical service center by investing in target hospitals. at the same time, the company strives to further develop into a high-quality regional medical service center covering medical services, rehabilitation services and pension services. The ultimate goal of the company is to establish a national network of medical services through strategic mergers and acquisitions across the country. The company regards its management of Yang Si Hospital as the core part of the strategic planning, with the establishment of a regional medical service center in Shanghai, and the operation of Fuhua Hospital as an extension of the plan.

Suppliers of Young Hospital and Fu Wah Hospital. The supplies needed for the operation of Yang Si Hospital and Fu Wah Hospital mainly include drugs and medical consumables. During the period from February 21, 2014 to December 31, 2014, for the year ended December 31, 2015, and for the nine months ended September 30, 2016, the company's drug, consumable material costs and testing fees accounted for 55.1%, 59.6% and 63.6% of its general hospital service segment costs (all related to Fuhua Hospital), respectively. During the period, the company's drug, consumable material costs and testing fees accounted for 52.1%, 54.9% and 59.9% of the total revenue of the company's general hospital service division (all related to Fuhua Hospital), respectively.

It is recommended to subscribe carefully. The company is a hospital operation and management group led by a professional team with rich experience in hospital management. Seizing the opportunity brought about by China's economic transformation and medical reform, the company adopts an innovative business model to focus on the regional medical service market, providing management and consulting services for the largest non-public hospital in Shanghai, as the basis for the establishment of a regional medical service center. Determined to establish a platform, brand hospital operation and management group.

In terms of valuation, the company's 2016 price-to-earnings ratio is 22.45-26.32 times, and the price-to-book ratio is 3.65-3.69 times, which is reasonable compared with the median price-to-earnings ratio of the same industry. It is recommended to subscribe carefully.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment